Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis
Clinical efficacy of JAKi in D2T RA group did not differ from that in 2nd and non-D2T RA groups. Glucocorticoid use and multiple bDMARD/JAKi failure were poor prognostic factors for D2T RA.
Authors
- K. Mandai (ORCID: https://orcid.org/0000-0001-7599-7835)
- K. Mamoto (ORCID: https://orcid.org/0000-0002-7541-3745)
- Tadashi Okano (ORCID: https://orcid.org/0000-0002-8849-9824)
- Yutaro Yamada (ORCID: https://orcid.org/0000-0002-7895-7684)
- K Orita (ORCID: https://orcid.org/0000-0002-2557-6183)
- Kentaro Inui (ORCID: https://orcid.org/0000-0002-8747-7279)
- Tatsuya Koike (ORCID: https://orcid.org/0000-0002-1522-8740)
- Takahiro Iida (ORCID: https://orcid.org/0009-0004-0374-9399)
- Hiroaki Nakamura (ORCID: https://orcid.org/0000-0002-0593-8810)
- S. Anno (ORCID: https://orcid.org/0000-0002-7439-0721)
- Masahiro Tada (ORCID: https://orcid.org/0000-0003-3161-3929)
Institutions
- Osaka City University (JP)
- Search Institute (US)
- Osaka City General Hospital (JP)
- Yodogawa Christian Hospital (JP)
- Osaka Hospital (JP)
- Saiseikai Nakatsu Hospital (JP)
- Nishinomiya Municipal Takagi Elementary School (JP)
- Osaka Metropolitan University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1093/mr/roae077
- Citations
- 2
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.94